Mergers & Acquisitions Mergers & Acquisitions

Change Healthcare executive grilled by US DOJ over competitive viability of proposed divestiture

By Khushita Vasant
  • 04 Aug 2022 01:26
  • 04 Aug 2022 03:40
Counsel for the US Department of Justice today asked an executive at Change Healthcare about the competitive viability of a standalone claims editing business that Change proposes to divest to gain antitrust approval for a multi-billion-dollar merger with UnitedHealth Group.
Kris Joshi, executive vice president at Change Healthcare, took the

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Khushita Vasant

Chief Antitrust Correspondent, US


Khushita covers US antitrust enforcement and litigation for MLex. A former Brussels hand, she wrote about about antitrust & mergers for the Policy and Regulatory Report (PaRR), she has covered the EU's actions against Google, Apple, Facebook and Amazon to name a few. Khushita specialises in tech and patent policy coverage which featured in the Concurrences Antitrust Writing Awards. Previously as a financial journalist for The Wall Street Journal and Dow Jones Newswires, she wrote about monetary policy and the bond and currency markets. Khushita studied journalism at Mumbai University, and received an Erasmus Mundus scholarship for a masters from universities in Germany and Austria.

Discover MLex

Stay on top of global regulatory developments

Latest News